NCT07288372
The CGM-OGTT Glycemic Homeostasis Study
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved at least 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jan 1, 2027 to Jun 30, 2027 Show 6 more changesShow less
- Recruitment opened
- Eligibility criteria expanded, about 12 words
- Study sites: 0 to 1
- Start date changed from estimate of Dec 18, 2025 to Dec 26, 2025
- Secondary endpoints: details revised at 4 of 23 entries
- Study description revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Correlation between MMTT-induced glucose AUC and OGTT plasma glucose values
Timeframe: MMTT: 0-3 hours post-meal (for AUC calculation). OGTT: 0, 30, 60, 120, and 180 minutes (for plasma glucose values).
Secondary (23)
Glycemic Variability (GV)
Dietary Macronutrient Intake Composition
Caloric Intake per Meal
Mean Amplitude of Glycemic Excursions (MAGE)
Complexity of Glucose Time Series
Show 18 moreShow less
Glucose AUC after MMTT
Glucose Levels During OGTT
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)
Incidence of Postprandial Hypotension during OGTT
Maximum reduction in systolic blood pressure (SBP) during OGTT
Completion Rate of Home-based MMTT
Adverse Events during OGTT /MMTT
GLP-1 serum concentration during OGTT
GIP serum concentration during OGTT
Insulin serum concentration during OGTT
C-peptide serum concentration during OGTT
Total GLP-1 AUC during OGTT
Total GIP AUC during OGTT
Association between Incretin Secretion and Glycemic Complexity
Time to Peak Glucose after Each Meal
Maximum reduction in diastolic blood pressure (DBP) during OGTT
Glycated hemoglobin (HbA1c) level
Glycated albumin (GA) level
Arms and interventions
Normal Glucose Tolerance (NGT)
Participants with normal glucose tolerance as defined by a 2-hour plasma glucose value \< 7.8 mmol/L during the oral glucose tolerance test (OGTT).
Pre-diabetes (Pre-DM)
Participants with pre-diabetes (intermediate hyperglycemia) as defined by a 2-hour plasma glucose value between 7.8 mmol/L and 11.0 mmol/L during the OGTT.
Newly Diagnosed Type 2 Diabetes (T2DM)
Participants with newly diagnosed type 2 diabetes as defined by a 2-hour plasma glucose value ≥ 11.1 mmol/L during the OGTT.
Sites
1 site in 1 country
- Shanghai Sixth People's HospitalShanghai, China